Decline depth
-31.7%
From rolling 252-day high of $1,525.17, 170d ago.
Past the 30% Amber threshold.
Amber List
MTD
Mettler-Toledo International, I
Healthcare · Diagnostics & Research · large-cap ($22.8B)
-31.7%
from rolling 252-day high of $1,525.17 set 2025-11-25 · 170d ago
Current
$1,041.91
Decline depth
-31.7%
Decline σ
6.0σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
MTD qualifies for the Amber List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
6.0σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.96% per day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about MTD.
MTD qualifies for the Amber List on decline depth — down -31.7% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 6.0σ over 20 bars.
Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $1,096.43
0.0% of range
52W high $1,525.17
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
42
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to MTD
Amber List
COLL
Collegium Pharmaceutical, Inc.
Red List
VREX
Varex Imaging Corporation
Amber List
TDOC
Teladoc Health, Inc.
Amber List
IQV
IQVIA Holdings, Inc.
Amber List
RMD
ResMed Inc.
Amber List
EYPT
EyePoint, Inc.
Questions about MTD
What people ask.
Why is MTD on Broken Stocks?
MTD qualifies for the Amber List on decline depth. It is down -31.7% from its rolling 252-day high of $1,525.17, set on 2025-11-25 — 170d ago.
Is MTD a falling knife?
Not by the strict technical definition. MTD is down -31.7% from its 52-week high, but that high was set 170d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. MTD is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is MTD a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is MTD trading inside its 52-week range?
At $1,041.91, MTD sits 0.0% of the way from its 52-week low ($1,096.43) to its 52-week high ($1,525.17). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has MTD been declining?
The current 31.7% decline accrued over 170d, which annualizes to roughly -68.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does MTD compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — MTD's decline is shallower than the sector median.
Does MTD's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.